SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-074930
Filing Date
2021-03-09
Accepted
2021-03-09 16:35:02
Documents
4
Effectiveness Date
2021-03-09

Document Format Files

Seq Description Document Type Size
1 S-8 d149755ds8.htm S-8 47760
2 EX-5.1 d149755dex51.htm EX-5.1 7260
3 EX-23.2 d149755dex232.htm EX-23.2 1679
4 GRAPHIC g149755dsp6.jpg GRAPHIC 3388
  Complete submission text file 0001193125-21-074930.txt   62563
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254039 | Film No.: 21726376
SIC: 2836 Biological Products, (No Diagnostic Substances)